More Vertical Integration, Tirzepatide vs. Semaglutide, & GLP-1 compounding data

ZorroCard Round Up (12/9/24)

Employer Sponsored vs. ACA Plans, Pharmacy Closures, & Chocolate In Type 2 Diabetes

ZorroCard Round Up (12/5/24)

Minnesota 340B Analysis, US vs. Canadian Drug Access, & Cancer Patient Assistance Funds Disappear

ZorroCard Round Up (12/4/24)

Ozempic for $290, Fixing Employer Healthcare, & The Supreme Court Ro Rule On FDA Vape Regulations

ZorroCard Round Up (12/3/24)

Food As Medicine Infrastructure, The Growing Health Gap, & Health Systems Fleeing Medicare Advantage

ZorroCard Round Up (12/2/24)

UHC Self-Dealing, Feds Seize Steward Execs’ Phones, & Biologics Market Exclusivity

ZorroCard Round Up (11/27/24)

PBM Malfeasance Data, 340B Data, & GLP-1 Coverage

ZorroCard Round Up (11/26/24)

US Drug Spending, Sanofi’s 340B Play, & A Letter To Dr. Oz

ZorroCard Round Up 11/25/24

Rx Costs Up 8.6%, Anthem Getting Sued, & Doulas Improve Outcomes

The ZorroCard Round Up For 11/21/24

GLP-1s for Alcohol Abuse, Costs of Privatizing VA, & Medicaid Unwinding’s Impact On Employers

ZorroCard Round Up (11/20/24)

AI Powered Surgical Robots, Semaglutide Reduces Admissions, & Reduced Competition in Small Business Market (ZorroCard Round Up 11/19/24)

ZorroCard Round Up (11/18/24)

Rising Obesity Rates, Why Forward Health Failed, & Hospital Performs >200k Unnecessary Back Surgeries